B
BVS icon

Bailard’s Bioventus BVS Stock Holding History

Bailard’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37,800
Closed -$250K – 797
2025
Q2 		$250K Buy
37,800
+7,100
+23% +$50.3K 0.01% 669
2025
Q1 		$281K Hold
30,700
– – 0.01% 591
2024
Q4 		$322K Sell
30,700
-15,400
-33% -$182K 0.01% 552
2024
Q3 		$551K Hold
46,100
– – 0.01% 448
2024
Q2 		$265K Sell
46,100
-76
-0.2% -$417 0.01% 582
2024
Q1 		$240K Sell
46,176
-12,053
-21% -$58.9K 0.01% 641
2023
Q4 		$307K Buy
+58,229
New +$230K 0.01% 548

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bailard's BVS Position: Q3 2025 in Review

Bailard sold out of Bioventus (BVS) in Q3 2025, closing a stake of 37,800 shares — an estimated $250K sold.

Bailard first reported a position in BVS in Q4 2023 and held it in 7 quarters. The position peaked at $551K in Q3 2024. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Bailard reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Bailard sold 37,800 Bioventus shares in Q3 2025, an estimated $250K.
  • Bailard first reported a position in Bioventus in Q4 2023 and held it in 7 quarters.
  • Bailard's Bioventus position peaked at $551K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Bailard's 13F filing for Q3 2025, filed 30 Oct 2025.